Belkyra

Belkyra (Deoxycholic Acid) is a prescription medication used for subcutaneous injection to reduce moderate to severe convexity or fullness associated with submental fat. It is a non-surgical option for improving the appearance of double chins. Belkyra is manufactured by AbbVie, Lda. and originates from the EU.

Belkyra is primarily used for aesthetic purposes to reduce submental fat, commonly known as a double chin. The active ingredient, Deoxycholic Acid, works by destroying fat cells in the treatment area. This medication is administered via subcutaneous injection and is designed for those seeking a non-surgical solution to improve facial contours. Belkyra is often considered for individuals who are bothered by the appearance of submental fullness and have not achieved satisfactory results with diet and exercise.

Common effects of Belkyra may include swelling, bruising, pain, numbness, redness, and areas of hardness in the treatment area. These effects are typically temporary and resolve within a few days to weeks. Some individuals may experience more pronounced side effects, and it is important to follow the advice of a healthcare provider regarding any concerns.

Belkyra should be used with caution and only under the supervision of a healthcare professional. It is important to disclose any medical conditions, allergies, or medications you are taking before starting treatment. Pregnant or breastfeeding women should consult their healthcare provider before using Belkyra. Always follow the prescribed dosage and administration instructions to minimize the risk of adverse effects.

Belkyra may interact with other medications or substances. It is important to inform your healthcare provider about all medications, including over-the-counter drugs, vitamins, and herbal supplements, that you are taking. Avoid alcohol and other substances that may increase the risk of side effects. Always consult your healthcare provider for personalized advice regarding potential interactions.